Tidal Investments LLC lifted its stake in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 158.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 46,159 shares of the real estate investment trust's stock after purchasing an additional 28,326 shares during the period. Tidal Investments LLC's holdings in Omega Healthcare Investors were worth $1,879,000 at the end of the most recent quarter.
Several other institutional investors also recently added to or reduced their stakes in the stock. Wealth Enhancement Advisory Services LLC increased its stake in shares of Omega Healthcare Investors by 9.5% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 41,839 shares of the real estate investment trust's stock valued at $1,433,000 after buying an additional 3,616 shares during the period. Focus Financial Network Inc. increased its position in Omega Healthcare Investors by 10.4% during the 2nd quarter. Focus Financial Network Inc. now owns 35,364 shares of the real estate investment trust's stock valued at $1,266,000 after purchasing an additional 3,327 shares during the period. Fifth Third Bancorp raised its holdings in shares of Omega Healthcare Investors by 33.9% in the 2nd quarter. Fifth Third Bancorp now owns 7,694 shares of the real estate investment trust's stock valued at $264,000 after purchasing an additional 1,950 shares in the last quarter. Fifth Third Wealth Advisors LLC purchased a new stake in shares of Omega Healthcare Investors in the 2nd quarter worth approximately $271,000. Finally, Bay Colony Advisory Group Inc d b a Bay Colony Advisors boosted its stake in shares of Omega Healthcare Investors by 4.7% during the second quarter. Bay Colony Advisory Group Inc d b a Bay Colony Advisors now owns 7,574 shares of the real estate investment trust's stock valued at $259,000 after purchasing an additional 342 shares in the last quarter. Hedge funds and other institutional investors own 65.25% of the company's stock.
Insider Activity
In other news, CFO Robert O. Stephenson sold 22,542 shares of the company's stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the sale, the chief financial officer now directly owns 183,076 shares of the company's stock, valued at $7,357,824.44. This represents a 10.96 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Daniel J. Booth sold 56,725 shares of the firm's stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now directly owns 100,000 shares of the company's stock, valued at approximately $4,025,000. This trade represents a 36.19 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.37% of the company's stock.
Omega Healthcare Investors Stock Performance
Omega Healthcare Investors stock traded up $0.33 during mid-day trading on Tuesday, reaching $39.34. 1,449,414 shares of the company traded hands, compared to its average volume of 1,685,851. The firm's fifty day moving average is $40.37 and its two-hundred day moving average is $38.02. The company has a market capitalization of $10.62 billion, a price-to-earnings ratio of 28.67, a price-to-earnings-growth ratio of 1.22 and a beta of 0.98. Omega Healthcare Investors, Inc. has a fifty-two week low of $27.53 and a fifty-two week high of $44.42. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.48 and a quick ratio of 6.48.
Omega Healthcare Investors Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were paid a dividend of $0.67 per share. The ex-dividend date was Monday, November 4th. This represents a $2.68 annualized dividend and a yield of 6.81%. Omega Healthcare Investors's payout ratio is presently 197.06%.
Wall Street Analysts Forecast Growth
A number of analysts have weighed in on the company. BMO Capital Markets upgraded Omega Healthcare Investors from a "market perform" rating to an "outperform" rating and set a $45.00 target price for the company in a report on Monday, December 9th. Scotiabank raised their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "sector perform" rating in a research report on Monday, August 26th. Mizuho lifted their target price on Omega Healthcare Investors from $35.00 to $37.00 and gave the company a "neutral" rating in a research note on Thursday, December 5th. Truist Financial increased their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "hold" rating in a research report on Wednesday, September 4th. Finally, Berenberg Bank began coverage on shares of Omega Healthcare Investors in a research report on Friday, October 18th. They issued a "buy" rating and a $45.00 price objective on the stock. Six analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $40.18.
Get Our Latest Stock Analysis on Omega Healthcare Investors
Omega Healthcare Investors Profile
(
Free Report)
Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.
See Also
Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.